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ABSTRACT
Background: Diverticular disease is a widely prevalent
disease in western society, and acute diverticulitis is a
common acute surgical presentation. However, there is
a lack of level 1 evidence addressing the multifaceted
presentations associated with acute diverticulitis. There
is also a lack of robust epidemiological data that could
be used to meaningfully inform randomised controlled
trials. The National CADS project aims to generate
baseline data for a cohort of patients managed for
clinically suspected acute diverticulitis and evaluate the
impact of variability in the management approach on
patient outcomes in the short (3 months) and long
(2 years) term.
Method: A Unit policy questionnaire will be completed
by the principal investigator from all participating
centres prior to study initiation. All patients aged above
18 years admitted with clinical suspicion of acute
diverticulitis will be included from UK hospitals
providing acute surgical care. Demographic, clinical,
inpatient stay and outpatient follow-up data will be
collected for index admissions between July and
September 2014, 3 months follow-up and finally a 2-
year follow-up.
Results: The study attracted participation from 108
centres nationally and has so far generated data on
2500 patients admitted between 1 July 2014 and 30
September 2014. Short-term follow-up data have been
obtained for this cohort.
Conclusions: The National CADS study is currently
ongoing with the long-term outcomes data anticipated
to be submitted in autumn of 2016.
INTRODUCTION
Diverticular disease, as deﬁned by the pres-
ence of diverticula along the colon, is wide-
spread in the ageing western population and
predominantly so along the left colon.1 Its
aetiology is unclear, presentation is varied
and prognosis diverse. The generally
accepted risk factors are advancing age, low-
ﬁbre diet and long-standing constipation. By
itself, diverticular disease is asymptomatic.
Inﬂammation within the diverticula can
result in diverticulitis which usually presents
with abdominal pain and tenderness some-
times accompanied with dark-coloured rectal
bleeding. The more serious sequelae include
formation of a diverticular abscess, perfor-
ation causing faecal peritonitis or formation
of colovesical/colovaginal ﬁstulae.2
While the management of uncomplicated
diverticulitis is achievable within the commu-
nity,3 a certain proportion of patients are
unfortunate enough to develop severe diver-
ticulitis and require hospital admission and a
more aggressive management approach.
Acute diverticulitis forms a common general
surgical emergency workload. There are,
however, gross inconsistencies in treatment
strategies across centres within the UK and
often even policies within general surgical units
vary from consultant to consultant. The reasons
for this are poorly understood and despite the
commonness of this condition, anecdotal evi-
dence reigns supreme in its management.4–6
Complicating the situation further is the
progressively increasing presentation of
younger and younger patients with compli-
cated acute diverticulitis.7 It is not difﬁcult to
imagine how each of the approaches alluded
to above could be a dilemma in themselves
when faced with patients sometimes as young
as in their 20s.8 9
Rationale for study
Exploring the literature reveals numerous
studies looking into various aspects of diver-
ticulitis. Good-quality randomised controlled
trials are few and their patient numbers are
small.10–16 The latest published review by
McDermott et al17 looking into laparoscopic
and open management in diverticulitis,
found trials with a cumulative of only 800
patients worldwide managed laparoscopically,
has concluded that more data are needed.
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This sets the scene for deﬁning the existing trends
and variability in approach within the UK. An evaluation
of existing practice and related outcomes would enable
identiﬁcation of true issues, deﬁne the baseline and
most importantly, aid formulation of appropriate
research questions for future studies based on concrete
data.
Study question
‘Is there variability in the management of acute diver-
ticulitis between centres and how is this related to
patient outcome in the short and long term?’.
Study design
Multicentre prospective observational study.
Objectives
To deﬁne
1. Management trends across centres
2. Regional variations
3. Short-term outcomes
▸ Conservative management
▸ Stoma rate
▸ Operative intervention
▸ Minimally invasive intervention
▸ ITU admission
▸ Thirty-day mortality
▸ Elective resection
▸ Readmission rate
▸ Restoration of bowel continuity
4. Long-term outcomes
▸ Elective/emergency operative intervention
▸ Stoma rate
▸ Mortality
▸ Readmission rate
▸ Restoration of bowel continuity
5. Parameters for future trials/interventional studies
METHODS
Any UK-based centre providing acute general surgical
inpatient service is eligible. Each centre must nominate
a consultant surgeon as principal investigator (PI) who
would support the smooth conduct of the study in that
centre. The PI would also take responsibility of provid-
ing follow-up data at 3 months and nominate juniors as
appropriate to collect these data as trainees would have
moved on by this time. Preferably, a team of junior
doctors involving registrars and SHOs should be
recruited to collect data. The study will run over the
period of 3 months and it should be ensured that a
member from the team is able to collect data every day
to avoid missing patients out. It is advisable that within
each region, registrars form a network and pick up the
project to the centre they would move to after the
changeover in August/October 2014.
Each high-volume centre must provide at least 15
patients within the 3-month period with follow-up data
to be eligible for inclusion in the analysis stage. Refer to
the Expected recruitment section for more details. After
considering the feedback from the consultation phase,
the minimum patients provided by smaller/rural centres
has been relaxed to 5 as these centres form an import-
ant component of the study question and their participa-
tion is thus highly desired.
Prior to the initiation of the study, an anonymised
questionnaire would be sent out to all PIs evaluating the
unit policies with regard to the management of diver-
ticulitis. This is only for purposes of comparing
approaches with outcomes and individual surgeons or
units will not be identiﬁable in the analysis of results.
Patient eligibility
Inclusion criteria
All patients aged 18 years or above admitted acutely with
‘clinically suspected acute diverticulitis’ and/or ‘radio-
logically conﬁrmed acute diverticulitis’. Patients dis-
charged within 24 hours of admission without any
investigations, radiological or otherwise, should also be
included. Patients with a subsequent radiological (or
endoscopic) diagnosis of diverticulitis or related compli-
cations during the course of their index admission
should also be included even if the initial working diag-
nosis was otherwise.
Exclusion criteria
Patients admitted without an initial clinical suspicion of
diverticulitis and happen to have diverticular disease as a
comorbidity. Which means, for example, they were
admitted with large bowel obstruction and CT revealed
diverticular disease but NO acute diverticulitis, then
such patients are to be excluded since their reason for
admission was unrelated to acute diverticulitis. Thus, a
diagnosis of incidental diverticular disease unrelated to
current presenting illness has to be excluded because
clearly such a patient is not presenting with complicated
diverticulitis but with just incidental diverticular disease.
Study period
Phase I
Data collection will start on 1 July 2014 from 08:00 hours
and cease on 30 September 2014 at 17:00 hours.
Phase II
Follow-up data will be obtained for all patients in the
month of January 2015 as this will be at least 3 months
follow-up for the last patient from 30 September 2014.
Phase III
Follow-up data will be obtained for all patients in the
month of October 2016 as this will be at least 2 years
follow-up for the last patient from 30 September 2014.
Mode of data collection
All data must be entered in the secure online database
using the provided access details only. Any hard copies
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of data must either be destroyed or kept safely until the
data have been uploaded on the database.
For the purposes of follow-up, names and hospital
numbers must be kept locally on the secure, password
protected excel database. The local data protection is
the responsibility of the local audit team.
Each centre would be allocated a unique centre ID,
which should be used to allocate study IDs to each patient.
An excel sheet will be provided where patient study IDs
and their hospital unit numbers could be stored to enable
retrieval of follow-up data. These excel sheets should only
be saved responsibly on secure networks and desktops as
per individual trust’s data protection policy. On comple-
tion of phase I, the excel sheets should be emailed to our
team on our email ID info@cadsaudit.org.uk. We could
then send reminders nearer the time for phase II and also
save these as backup copies if needed.
Expected recruitment
As per the HES data for 2012/2013, the total number of
hospital admissions for ‘acute diverticulitis’ were 277 773
which is in excess of 27 000/month nationally. Similarly,
the number of admissions for ‘perforated diverticulitis’
was 8994 which is around 750/month nationally. It is
anticipated that each centre would have at least 1
patient/week and at most 5–7 patients/week. Thus, over
a 3-month period, it should not be difﬁcult to get 15
patients per centre for most urban centres.
Outcome measures
Primary
All-cause 30-day mortality will be the primary outcome
measure based on the rationale that a variation in man-
agement approach would have an impact on mortality.
Secondary
The following would be evaluated:
▸ Patient demographics
▸ Presenting symptoms
▸ Radiological classiﬁcation of severity; Hinchey
classiﬁcation
▸ Open/laparoscopic operative intervention
▸ Radiological intervention
▸ Conservative management
▸ Multiplicity of interventions
▸ Stoma rate/restoration of bowel continuity
▸ ITU admission
▸ Length of index hospital admission
▸ Acute readmission
▸ Elective resection
CADS committee structure
The CADS Study group would be a corporate author in
all publications/output and would comprise of the
following.
Core committee
Chief Investigators (SS, Chris Macklin, David Jayne)
The responsibility and ﬁnal authority with data hand-
ling, analysis and manuscript writing and submission will
rest with the core committee. Any future work generated
on the basis of this audit will also be under the initiative
of the core committee.
Steering committee
YSRC—SS; Greg Taylor; Stephen Chapman.
National Surgical Research Collaborative: Represented
by one contact from each regional collaborative. Refer
to the contributorship statement for details.
All registered participants from registered centres. It is
the responsibility of the PI to ensure that names of all
members of their local team are communicated to us.
Dissemination
Participants may present their local data at their depart-
ment audit/clinical governance meeting. National data
shall be presented at a national conference and will be
submitted for publication in a peer-reviewed journal.
Authorship
One trainee contact from each participating centre and
PIs would be recognised as part of the steering group
for the study. All other named local investigators from a
centre would be recognised as citable authors in the
manuscript. We recommend not more than four investi-
gators in total per each centre which includes PI, lead
trainee and up to two local investigators. As stated above,
at least 15 patients must be submitted by each centre (at
least 5 by small/rural centres) to be considered for the
analysis and publication stage. A minimum of 10 cases
must be submitted per each local investigator (this
excludes PI and lead trainee), that is, a centre claiming
three local investigators must submit at least 30 patients’
data. There is no upper limit for patient numbers per
authors and the lower limit is only to discourage unwar-
ranted numbers of local investigators. A minimum of
three centres must participate for the regional collabora-
tive to be recognised.
Any publications/presentations arising out with the
remit of the project must ﬁrst obtain permission from
the CADS Core Group. Such publications/presentations
using the national data set must include members of the
CADS Core group as named authors and the ‘CADS
Study group’ as a corporate author. Publications using
only local or part of the national data set must include
members of the CADS Core group as named authors.
Disclaimer
The CADS core committee reserves the right to review
and amend this protocol within reason during the
course of the audit to enable delivery of the project to
the highest standards.
Twitter Follow Shafaque Shaikh at @cadsaudit
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